Stock Options

6 Months Ended

Mar. 31, 2018

Stock Options [Abstract]

STOCK OPTIONS

9. STOCK OPTIONS

For the period ended March 31, 2018, the Company recorded no share-based compensation expense related to stock options (September 30, 2017 – $2,314). As of March 31, 2018, there was no unrecognized compensation cost related to option awards. Compensation expense is based upon straight-line depreciation of the grant-date fair value over the vesting period of the underlying unit option.

	Shares Underlying Options Outstanding						Shares Underlying Options Exercisable
Range of Exercise Price	Shares Underlying Options Outstanding		Weighted Average Remaining Contractual Life		Weighted Average Exercise Price		Shares Underlying Options Exercisable		Weighted Average Exercise Price
$0.05 at March 31, 2018		3,450,000		0.22		0.05		3,450,000		0.05
$0.30 at March 31, 2018		250,000		0.58		0.30		250,000		0.30
$0.34 at March 31, 2018		450,000		0.68		0.34		450,000		0.34
$0.38 at March 31, 2018		6,780,000		1.47		0.38		6,780,000		0.38
$0.23 at March 31, 2018		600,000		1.63		0.23		600,000		0.23
		11,530,000		1.06	$	0.27		11,530,000	$	0.27

The aggregate intrinsic value of exercisable options as of March 31, 2018, was $Nil (September 30, 2017 - $Nil).

The following is a summary of stock option activity as at March 31, 2018:

	Number of Underlying Shares		Weighted Average Exercise Price		Weighted Average Fair Market Value
Balance, September 30, 2017		11,530,000	$	0.27	$	0.22
Balance, March 31, 2018		11,530,000	$	0.27	$	0.22
Exercisable, March 31, 2018		11,530,000	$	0.27	$	0.22

There were no remaining unvested stock options outstanding as of March 31, 2018 (September 30, 2017 – Nil).